Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI
- Posted on November 11, 2024
- By Business News Today
- 1 Views
Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI
Biocon shares surged 5.4% after FDA classified its Bengaluru facility as Voluntary Action Indicated (VAI). The stock is up 47.7% YoY, supported by strong technical indicators.
